On this page
Loeys-Dietz syndrome
This syndrome is characterised by features such as aortic aneurysm, skeletal abnormalities, and distinct facial features. It is caused by changes in certain genes, typically inherited in an autosomal dominant pattern, and can affect individuals from infancy into adulthood.
Available at Jeen Health
Clinical tests that include this
Overview
Loeys-Dietz syndrome is a rare genetic disorder that impacts connective tissue throughout the body. Connective tissue provides strength and flexibility to many parts of the body, including blood vessels, bones, skin, and internal organs. The syndrome is named after the doctors who first described it in 2005. Individuals with Loeys-Dietz syndrome often present with a combination of features, including an increased risk of aortic aneurysms and dissections, skeletal abnormalities, and distinctive facial characteristics [PMID:15735626].
While Loeys-Dietz syndrome shares some features with other connective tissue disorders, such as Marfan syndrome, it is distinguished by a higher risk of aggressive arterial disease, even in early childhood. The presentation of the syndrome can vary significantly among affected individuals, even within the same family. Early diagnosis and careful management are crucial for individuals with Loeys-Dietz syndrome to monitor for potential complications and guide appropriate medical care.
Symptoms & clinical features
The clinical features of Loeys-Dietz syndrome are diverse and can affect various body systems. Common cardiovascular symptoms include an enlarged aorta (aortic aneurysm) and, less commonly, bicuspid aortic valves [PMID:24076062]. The aorta is the body's main artery, and its enlargement can lead to a dangerous tear (dissection) without warning. Other blood vessels throughout the body may also be affected.
Skeletal abnormalities are frequently observed, such as scoliosis (curvature of the spine), chest wall deformities (e.g., pectus excavatum or carinatum), joint hypermobility, and long, slender fingers and toes (arachnodactyly). Some individuals may have craniosynostosis, where the skull bones fuse too early, affecting head shape. Distinctive facial features can include widely spaced eyes (hypertelorism), a split uvula or cleft palate, and twisting of the blood vessels in the whites of the eyes [PMID:15735626]. Skin findings like easy bruising or translucent skin and allergic manifestations, such as asthma or food allergies, are also commonly reported.
Video: Genetics 101
Affected organs
Loeys-Dietz syndrome primarily affects the cardiovascular system, with the aorta being a major concern. The aorta, and other arteries throughout the body, can become weakened and prone to aneurysm formation or dissection. This can affect arteries in the chest, abdomen, brain, and limbs. The skeletal system is also commonly involved, with potential impacts on the spine, ribs, and joints.
Other body systems can be affected to varying degrees. The eyes may show features like widely spaced eyes or blue sclera (the whites of the eyes). The gastrointestinal system can sometimes experience issues such as intestinal malrotation or diverticulosis. The skin and integumentary system may exhibit easy bruising, velvety texture, or abnormal wound healing. While the syndrome is systemic, the most life-threatening complications typically involve the cardiovascular system.
Risks & severity
The severity of Loeys-Dietz syndrome can vary widely, even among individuals with the same genetic change. A significant risk is the development of aortic aneurysms and dissections, which can occur at any age, including during childhood, and may be more aggressive than in other similar conditions [PMID:24076062]. The risk of aortic dissection is a major factor influencing life expectancy without appropriate medical management.
Age of onset for symptoms is also variable; some individuals are diagnosed in infancy due to early cardiovascular issues or distinct facial features, while others may not receive a diagnosis until later in life. Regular monitoring of the aorta and other blood vessels is essential to manage these risks effectively. Some individuals may experience mild skeletal features, while others may have more pronounced issues requiring orthopaedic intervention. Exact prevalence figures for Loeys-Dietz syndrome are not well established, but it is considered a rare condition.
Genetic causes
Loeys-Dietz syndrome is caused by pathogenic variants in genes that are part of the transforming growth factor beta (TGF-β) signalling pathway. The most commonly implicated genes are TGFBR1 and TGFBR2 [PMID:15735626]. Less commonly, variants in other genes within this pathway, such as SMAD2, SMAD3, TGFB2, and TGFB3, can also cause the syndrome.
TGFBR1 and TGFBR2 genes provide instructions for making proteins that act as receptors for TGF-β. These receptors sit on the surface of cells and receive signals from outside the cell, which are then transmitted inside. The TGF-β pathway plays a critical role in controlling cell growth, development, and repair, especially in connective tissue. Pathogenic changes in TGFBR1 or TGFBR2 disrupt this signalling pathway, leading to the characteristic features of Loeys-Dietz syndrome by affecting the integrity and function of connective tissue throughout the body.
- TGFBR1 transforming growth factor beta receptor 1The *TGFBR1* gene provides instructions for making a protein that plays a crucial role in cell signalling, influencing processes like cell growth, division, and maturation.
- TGFBR2 transforming growth factor beta receptor 2The *TGFBR2* gene provides instructions for making a protein central to cell signalling, influencing processes such as cell growth, division, and differentiation.
Inheritance pattern
Loeys-Dietz syndrome is typically inherited in an autosomal dominant pattern. This means that a person only needs one copy of an altered gene to develop the condition. If a parent has Loeys-Dietz syndrome, there is a 50% chance with each pregnancy that their child will inherit the pathogenic variant and develop the syndrome.
In about 75% of cases, the condition results from a new (de novo) pathogenic variant, meaning it occurs in the affected individual for the first time and was not inherited from either parent. In these situations, the parents are unaffected and typically do not carry the gene change. Genetic counselling can provide detailed information about inheritance patterns and risks for family members.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosis of Loeys-Dietz syndrome is usually based on a combination of characteristic clinical features and confirmed by genetic testing. Clinical features that may prompt consideration of Loeys-Dietz syndrome include the presence of aortic enlargement, skeletal abnormalities, and specific craniofacial features. Imaging studies, such as echocardiograms or CT scans, are essential to assess the aorta and other blood vessels.
Genetic testing, often performed using a multi-gene panel that includes TGFBR1 and TGFBR2, can identify the specific pathogenic variant causing the condition. In the UK, genetic testing for suspected Loeys-Dietz syndrome would typically be requested by a clinical geneticist or a specialist within the NHS Genomic Medicine Service. The relevant NHS Genomic Test Directory R-codes would apply, such as R328 for Marfan and related disorders, to guide the testing pathway.
Management & lifestyle
Management of Loeys-Dietz syndrome focuses on regular monitoring, symptom management, and preventative measures to reduce the risk of serious complications, particularly those affecting the cardiovascular system. Regular imaging of the aorta, typically with echocardiography, MRI, or CT scans, is crucial to monitor for aneurysm progression. Medication, such as beta-blockers or angiotensin receptor blockers, may be prescribed to help reduce stress on the aorta and slow its enlargement [PMID:24076062].
Surgical intervention may be recommended to repair or replace sections of the aorta if it reaches a certain size or grows rapidly, even if asymptomatic. Other clinical features, such as scoliosis or cleft palate, are managed according to standard medical practice by relevant specialists. Individuals with Loeys-Dietz syndrome are typically advised to avoid strenuous physical activities that could increase the risk of aortic dissection. A multidisciplinary team, including cardiologists, geneticists, and orthopaedic specialists, often provides care. Genetic counsellors offer support and information to individuals and families regarding the condition, inheritance, and family planning.
UK care pathway
In the UK, individuals suspected of having Loeys-Dietz syndrome would typically be referred to a clinical genetics service. This specialist service is part of the NHS Genomic Medicine Service, which provides access to genetic testing and expert genetic counselling. A clinical geneticist would assess the individual's symptoms and family history to determine the most appropriate diagnostic pathway, including genetic testing as per the NHS Genomic Test Directory (e.g., using relevant R-codes for connective tissue disorders). Genetic counsellors play a vital role in explaining genetic test results, inheritance patterns, and the implications for the wider family, as well as providing psychological support.
Ongoing management often involves a network of specialist care, coordinating between cardiologists, orthopaedic surgeons, and other relevant specialists, usually managed within NHS trusts with expertise in rare and complex conditions. Surveillance for aortic involvement is a key part of the care pathway.
Frequently asked questions
What is the main danger of Loeys-Dietz syndrome?
The most significant risk is the weakening and enlargement of the aorta, the main artery of the body. This can lead to an aortic aneurysm (a bulge) or dissection (a tear), which can be life-threatening if not managed appropriately. Regular monitoring of the aorta is crucial.
Can Loeys-Dietz syndrome be inherited?
Yes, Loeys-Dietz syndrome is inherited in an autosomal dominant pattern. This means if a parent has the condition, there's a 50% chance with each child they will pass on the genetic change. However, in many cases, it arises as a new genetic change in the affected individual.
Is there a cure for Loeys-Dietz syndrome?
There is currently no cure for Loeys-Dietz syndrome. However, symptoms can be managed effectively through regular medical monitoring, medications, and sometimes surgical interventions, especially for the aorta. This approach aims to reduce risks and improve quality of life.
How is Loeys-Dietz syndrome diagnosed in the UK?
Diagnosis in the UK typically involves clinical assessment by a specialist, often a clinical geneticist, followed by genetic testing. This testing looks for pathogenic changes in specific genes like TGFBR1 and TGFBR2, which can confirm the diagnosis. Imaging tests like echocardiograms are also used to check for heart and blood vessel issues.
Are there activities I should avoid if I have Loeys-Dietz syndrome?
Individuals with Loeys-Dietz syndrome are generally advised to avoid strenuous physical activities, heavy lifting, or contact sports that could put excessive stress on the aorta and increase the risk of dissection. Your medical team will provide personalised guidance based on your specific condition and aortic measurements.
References
- Gouda P, Kay R, Habib M. Clinical features and complications of Loeys-Dietz syndrome: A systematic review. International journal of cardiology. 2022. PMID: 35662564
- Velchev JD, Van Laer L, Luyckx I. Loeys-Dietz Syndrome. Advances in experimental medicine and biology. 2021. PMID: 34807423
- MacCarrick G, Black JH 3rd, Bowdin S. Loeys-Dietz syndrome: a primer for diagnosis and management. Genetics in medicine : official journal of the American College of Medical Genetics. 2014. PMID: 24577266
- MacCarrick G, Afifi RO, Allen R. Loeys-Dietz syndrome: 2026 updated care management primer. Genetics in medicine : official journal of the American College of Medical Genetics. 2026. PMID: 41988792
- Van Laer L, Dietz H, Loeys B. Loeys-Dietz syndrome. Advances in experimental medicine and biology. 2014. PMID: 24443023
- Meester JAN, De Kinderen P, Verstraeten A. Meester-Loeys Syndrome. Advances in experimental medicine and biology. 2021. PMID: 34807424
- Schepers D, Tortora G, Morisaki H. A mutation update on the LDS-associated genes TGFB2/3 and SMAD2/3. Human mutation. 2018. PMID: 29392890
- Pedroza AJ, Dalal AR, Kim J. Loeys-Dietz syndrome subtypes exhibit distinct clinical behavior and aortic cellular transcriptomic profiles. JTCVS open. 2025. PMID: 40923070